Cargando…
Acute hepatic injury with amphotericin B deoxycholate in an immunocompetent patient
Amphotericin B deoxycholate (AmBd) is rarely used due to its adverse effect profile, which includes nephrotoxicity, infusion-related reactions, and hepatotoxicity. The incidence of hepatotoxicity related to AmBd is 18–23%, but the reports of this adverse effect are mainly in immunocompromised patien...
Autores principales: | Wagner, Jamie L., Bell, Allison M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936079/ https://www.ncbi.nlm.nih.gov/pubmed/27440960 http://dx.doi.org/10.4103/0976-500X.184779 |
Ejemplares similares
-
Successful Treatment of Protothecal Tenosynovitis in an Immunocompetent Patient using Amphotericin B Deoxycholate
por: Kim, Ji-Eun, et al.
Publicado: (2017) -
Cyanotic Raynaud's phenomenon induced by amphotericin B deoxycholate: A case report
por: Hatem, Nayla A., et al.
Publicado: (2023) -
Effect of deoxycholate, amphotericin B and fongizone on transmissible gastroenteritis coronavirus
por: Nguyen, T.D., et al.
Publicado: (1987) -
Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate
por: Chandrasekar, PH
Publicado: (2008) -
In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates
por: Montagna, Maria Teresa, et al.
Publicado: (2014)